Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kinetics of Endocannabinoids in CIPN with Cannabis Inhaler
NCT04376437Unknown
- Sponsor
- Emek Medical Center
- Start
- Mar 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of medical cannabis in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Emek Medical Center. Primary endpoint: Changes in the level of 150 different endocannabinoids at 4 months. Status: unknown.
02
Drugs
medical cannabis
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT04376437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04376437.